Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Summary

Neurocrine Biosciences (Nasdaq: NBIX) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 1:20 p.m. ET. CEO Kevin Gorman will lead the presentation. Attendees can access the live webcast on the company's website, with a replay available about an hour after the event, archived for one month. Neurocrine focuses on developing treatments for neurological and endocrine disorders, with a portfolio that includes FDA-approved therapies for tardive dyskinesia, Parkinson's disease, and more.

SAN DIEGO, June 1, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 42^nd Annual Global Healthcare Conference at 1:20 p.m. Eastern Time on Tuesday, June 8, 2021. Kevin Gorman, Chief Executive Officer, will present at the conference.

The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)

View original content to download multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301303189.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

When is Neurocrine Biosciences presenting at the Goldman Sachs Conference?

Neurocrine Biosciences will present on June 8, 2021, at 1:20 p.m. ET.

Who is presenting for Neurocrine Biosciences at the conference?

CEO Kevin Gorman will present for Neurocrine Biosciences.

Where can I watch the Neurocrine Biosciences presentation?

The presentation can be accessed live on Neurocrine's website under the Investors section.

Will there be a replay of the Neurocrine Biosciences presentation?

Yes, a replay will be available approximately one hour after the presentation and archived for around one month.

What is the stock symbol for Neurocrine Biosciences?

The stock symbol for Neurocrine Biosciences is NBIX.